Publish-box
(todo)
This
is
the
Continuous
Integration
Build
of
FHIR
(will
be
incorrect/inconsistent
at
times).
See
the
Directory
of
published
versions
| Responsible Owner: Pharmacy Work Group | Standards Status : Informative | Compartments : Encounter , Group , Patient , Practitioner |
This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationDispense .
Generated Narrative: MedicationDispense meddisp0315
status
:
in-progress
In
Progress
| Reference |
| amylase / cellulase / hyoscyamine / lipase / phenyltoloxamine / protease Oral Capsule |
subject : Donald Duck
| Actor |
| Practitioner Rob van den Berk (official) |
authorizingPrescription : MedicationRequest: identifier = http://www.bmc.nl/portal/prescriptions#12345689 (use: official, ); status = completed; intent = order; authoredOn = 2015-01-15
type : Refill - Part Fill
quantity : 30(unit TAB from http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm) (Details: Orderable Drug Form codeTAB = 'Tablet')
daysSupply : 10 Day (Details: UCUM coded = 'd')
whenPrepared : 2015-06-25T07:13:00+05:00
whenHandedOver : 2015-06-26T07:13:00+05:00
dosageInstruction
sequence : 1
text : 0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015. Do not exceed more than 4mg per day
additionalInstruction : Warning. May cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink (qualifier value)
timing : Once per 6-12 hours
asNeededFor : Dysmenorrhea (disorder)
route : Oral Route
DoseAndRates
Type Dose[x] Ordered 1 TAB (Details: Orderable Drug Form codeTAB = 'Tablet')
Generated Narrative: Medication #med0314
code : amylase / cellulase / hyoscyamine / lipase / phenyltoloxamine / protease Oral Capsule
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.